Fri, 21 Jul 2017 13:30:19: Aeterna CEO Dodd out as company reviews options

Fri, 21 Jul 2017 12:09:27: News of NoteóBiotech IPOs; CHMP knockbacks

Fri, 21 Jul 2017 11:35:32: MHRA to move HQ to same area as EMAís London digs

Thu, 20 Jul 2017 20:09:46: Targeting inflammation could treat metabolic syndrome's many symptoms

Thu, 20 Jul 2017 15:50:51: Ironwood slips as heartburn data underwhelm investors†

Thu, 20 Jul 2017 14:44:32: Attacking muscle diseases like ALS by clearing protein clumps

Thu, 20 Jul 2017 13:46:11: News of NoteóTrevena CMO exit; AMO deal; Kala IPO; AliveCor-Mayo pact

Thu, 20 Jul 2017 12:33:52: Sanofi offers Ablynx billions of biobucks for nanobody partnership

Thu, 20 Jul 2017 12:03:42: Roche dumps Oryzonís epigenetic AML, solid tumor drug†

Thu, 20 Jul 2017 10:27:39: Theravance COPD drug clears safety study, setting up NDA

Thu, 20 Jul 2017 09:22:43: Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD work

Wed, 19 Jul 2017 14:09:56: News of NoteóDodgy stem cell clinics; New CMO for Context; UroGen payday

Wed, 19 Jul 2017 13:14:07: EU watchdog asks if drugmakers influence EMA decisions

Wed, 19 Jul 2017 12:24:15: Lilly firms up Adimab R&D alliance, bringing its Ab platform in-house

Wed, 19 Jul 2017 09:51:03: Japanís Fujifilm sees phase 2 flop for Alzheimerís candidate

Wed, 19 Jul 2017 09:28:37: Vertex cystic fibrosis drugs ace clinical trials, sparking 26% stock price surge

Tue, 18 Jul 2017 14:06:24: News of NoteóNektarís sweet data; Zymeworks bonus; Alzheimerís pipeline

Tue, 18 Jul 2017 12:40:23: Shire pens bispecific hemophilia R&D deal with Novimmune

Tue, 18 Jul 2017 12:32:55: Kleo taps PeptiDream for help with immuno-oncology programs

Tue, 18 Jul 2017 12:15:17: Abzena licenses PSMA antibodies to Telix to create cancer-targeting radioactive drugs

Tue, 18 Jul 2017 08:16:17: Paratek antibiotic hits endpoints in phase 3, teeing up NDA

Mon, 17 Jul 2017 12:50:40: CymaBay takes a peek at liver disease candidate data

Mon, 17 Jul 2017 12:29:29: Backers put $12.7M behind Enterin's Parkinson's disease approach

Mon, 17 Jul 2017 12:22:32: U.K. commits £86M to get medical advances into NHS faster

Mon, 17 Jul 2017 08:18:13: Safety scare prompts FDA to reject Amgenís romosozumab